Filing Details

Accession Number:
0001209191-10-017816
Form Type:
4
Zero Holdings:
No
Publication Time:
2010-03-18 13:00:00
Reporting Period:
2010-03-17
Filing Date:
2010-03-18
Accepted Time:
2010-03-18 16:02:30
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
786947 Acura Pharmaceuticals Inc ACUR Pharmaceutical Preparations (2834) 110853640
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1058352 G William Skelly C/O Acura Pharmaceuticals, Inc.
616 N. North Court
Palatine IL 60067
Yes No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2010-03-17 1,000 $5.55 100,000 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Direct
Footnotes
  1. Holdings listed are Restricted Stock Units and give effect to a 1 for 10 reverse stock split effective on December 5, 2007. Restricted Stock Units represent rights to an equivalent number of shares of common stock of the Issuer. Absent a change of control, 25,000 shares of common stock will be distributed under the Restricted Stock Units (after payment of $.01 par value per share) on January 1st of each 2011, 2012, 2013, and 2014. If a change of control occurs (whether prior to or after 2011), one share of common stock will be distributed for each outstanding Restricted Stock Unit (after payment of $.01 per share par value) at or about the time of the change of control.